American immunologist and Nobel laureate (born 1948)
James Patrick Allison (born August 7, 1948)[4] is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.[5] Allison is Regental Professor and Founding-Director of James P. Allison Institute at the MD Anderson Cancer Center.[6]
His discoveries have led to new cancer treatments for the deadliest cancers. He is also the director of the Cancer Research Institute (CRI) scientific advisory council. He has a longstanding interest in mechanisms of T-cell development and activation, the development of novel strategies for tumor immunotherapy, and is recognized as one of the first people to isolate the T-cell antigen receptor complex protein.[7][8]
In 2014, he was awarded the Breakthrough Prize in Life Sciences; in 2018, he shared the Nobel Prize in Physiology or Medicine with Tasuku Honjo.[9][10]
- ^ "First Tang Prize for Biopharmaceutical Science Awarded to James P. Allison, PhD, and Tasuku Honjo, MD, PhD". www.tang-prize.org. The ASCO Post. July 10, 2014. Retrieved August 4, 2016.
- ^ Foundation, Lasker. "Unleashing the immune system to combat cancer | The Lasker Foundation". The Lasker Foundation. Lasker Foundation. Retrieved August 4, 2016.
- ^ "James Allison wins 2018 Dr. Paul Janssen Award for Biomedical Research". Retrieved September 11, 2018.
- ^ a b "James P. Allison – Facts – 2018". NobelPrize.org. Nobel Media AB. October 1, 2018. Retrieved October 5, 2018.
- ^ "James P. Allison".
- ^ "James P. Allison Institute".
- ^ "James Allison". Cancer Research Institute. Retrieved August 4, 2016.
- ^ Blair, Jenny (May 2, 2014). "Raising the Tail". The Alcalde. Texas Exes. Retrieved October 3, 2018.
- ^ "2014 Tang Prize in Biopharmaceutical Science". Archived from the original on October 20, 2017. Retrieved June 18, 2016.
- ^ Devlin, Hannah (October 1, 2018). "James P Allison and Tasuku Honjo win Nobel prize for medicine". the Guardian. Retrieved October 1, 2018.